Romania Pharmaceuticals and Healthcare Report Q2 2012 (Related Reports)

Romania Pharmaceuticals and Healthcare Report Q2 2012


March 20, 2012
100 Pages - SKU: BMI3816816
License type:
Report with 3 quarterly updates      US $1,175.00
EMR 2014: The Market for Electronic Medical Records
4/2/2014 | published by: Kalorama Information
The EMR Industry Standard Kalorama has continuously examined the fast-changing market for electronic medical records (EMR) for nearly a decade, and each year we produce a comprehensive report of our findings.  Our report has become the industry  |  read more...
$3,995.00
Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023
4/7/2014 | published by: Kalorama Information
Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 Kalorama Information's Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 takes a considered look at the pharmaceutical  |  read more...
$3,995.00
Retail Clinics Market Overview and 2014 Survey Results
3/11/2014 | published by: Kalorama Information
Retail Clinics Market Overview and 2014 Survey Results Retail clinics are medical settings located in a retail store. They are not free standing and do not offer all medical  |  read more...
$750.00
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018
4/4/2014 | published by: MarketsandMarkets
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018 Over the  |  read more...
$4,650.00
Perspective: Cloud Solutions and Deployment for Healthcare Payers in 2014
4/10/2014 | published by: IDC
Perspective: Cloud Solutions and Deployment for Healthcare Payers in 2014 This IDC Health Insights Perspective examines the current status of cloud deployment by U.S. healthcare payers and their plans for cloud initiatives in 2014 and includes  |  read more...
$1,500.00
The Multi-Level Market for Weight Loss Products
4/1/2014 | published by: Marketdata Enterprises Inc.
The Multi-Level Market for Weight Loss Products In a U.S. weight loss market that’s characterized by flat to low growth, the MLM (multi-level marketing) sales model stands out as one of the few  |  read more...
$1,727.00
Pertussis - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Pertussis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pertussis - Pipeline Review, H1 2014’, provides an overview of the Pertussis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pertussis, complete with comparative  |  read more...
$2,000.00
Klebsiella Pneumoniae Infections - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Klebsiella Pneumoniae Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Klebsiella Pneumoniae Infections - Pipeline Review, H1 2014’, provides an overview of the Klebsiella Pneumoniae Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Polio - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Polio - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Polio - Pipeline Review, H1 2014’, provides an overview of the Polio’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Polio, complete with comparative  |  read more...
$2,000.00
Typhoid Fever - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Typhoid Fever - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Typhoid Fever - Pipeline Review, H1 2014’, provides an overview of the Typhoid Fever’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Typhoid  |  read more...
$2,000.00